Lista de obras - Mieczysław Komarnicki - Dominio Público Uruguay

Activity of bortezomib in adult de novo and relapsed acute myeloid leukemia

artículo científico publicado en 2007

Addition of cladribine to daunorubicin and cytarabine increases complete remission rate after a single course of induction treatment in acute myeloid leukemia. Multicenter, phase III study

artículo científico publicado en 2004

Analysis of boutique arrays: a universal method for the selection of the optimal data normalization procedure

artículo científico publicado en 2013

Assessing the efficacy of allogeneic hematopoietic stem cells transplantation (allo-HSCT) by analyzing survival end points in defined groups of acute myeloid leukemia patients: a retrospective, multicenter Polish Adult Leukemia Group study

artículo científico publicado en 2015

Assessment of coagulation profile by thromboelastometry in adult patients with cyanotic congenital heart disease

artículo científico publicado en 2015

Autologous hematopoietic stem cell transplant for progressive diffuse systemic sclerosis: procedural success and clinical outcome in 5-year follow-up

scholarly article by Katarzyna Pawlak-Buś et al published 2019 in Reumatologia

Autologous stem cell transplantation as consolidation therapy for patients with peripheral T cell lymphoma in first remission: long-term outcome and risk factors analysis

artículo científico publicado en 2013

B-Cell Chronic Lymphocytic Leukemia with 11q22.3 Rearrangement in Patient with Chronic Myeloid Leukemia Treated with Imatinib

artículo científico publicado en 2016

Bendamustine-based therapy as first-line treatment for non-Hodgkin lymphoma

artículo científico

Bleeding complications after arthroscopy in a JAK2V617F-positive patient with essential thrombocythemia and acquired von Willebrand syndrome (AVWS).

artículo científico publicado en 2014

Bortezomib has little ex vivo activity in chronic myeloid leukemia: individual tumor response testing comparative study in acute and chronic myeloid leukemia.

artículo científico publicado en 2012

Bortezomib in combination with thalidomide and dexamethasone--a successful treatment regimen in refractory extramedullary multiple myeloma

artículo científico publicado en 2007

Cancer procoagulant in patients with adenocarcinomas.

artículo científico publicado en 2005

Characterization and significance of the Philadelphia negative/BCR-ABL1 positive rearrangement or masked Philadelphia translocation in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a single-center study

scientific article published on 07 August 2019

Cladribine, but not fludarabine, added to daunorubicin and cytarabine during induction prolongs survival of patients with acute myeloid leukemia: a multicenter, randomized phase III study.

artículo científico publicado en 2012

Clinical usefulness of serum free light chains measurement in patients with multiple myeloma: comparative analysis of two different tests

artículo científico publicado en 2017

Coagulation profile in patients with H1N1 influenza A infection undergoing treatment for haematological malignancies

artículo científico publicado en 2014

Comparative proteome analysis of acute myeloid leukemia with and without maturation.

artículo científico publicado en 2012

Comparative proteomic profiling of sera from patients with refractory multiple myeloma reveals potential biomarkers predicting response to bortezomib-based therapy.

artículo científico publicado en 2017

Comparative proteomics in acute myeloid leukemia

artículo científico publicado en 2012

Comparison of clofarabine activity in childhood and adult acute leukemia: individual tumor response study.

artículo científico publicado en 2009

Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma

artículo científico publicado en 2016

Dasatinib treatment can overcome imatinib and nilotinib resistance in CML patient carrying F359I mutation of BCR-ABL oncogene

artículo científico publicado en 2008

Dasatinib-induced complete molecular response after allogeneic hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia resistant to prior imatinib-containing regimen: a case report and discussion

artículo científico publicado en 2009

Donor NK cell licensing in control of malignancy in hematopoietic stem cell transplant recipients.

artículo científico publicado en 2014

Esterase D and gamma 1 actin level might predict results of induction therapy in patients with acute myeloid leukemia without and with maturation

artículo científico publicado en 2013

Evaluation of risk factors and assessment models for predicting venous thromboembolism in lung cancer patients.

artículo científico publicado en 2018

Evaluation of the ThroLy score for the prediction of venous thromboembolism in newly diagnosed patients treated for lymphoid malignancies in clinical practice

scientific article published on 15 May 2018

Evaluation of thromboelastometry parameters as predictive markers for sinusoidal obstruction syndrome in patients undergoing allogeneic stem cell transplantation for acute leukaemia.

artículo científico publicado en 2017

Exercise capacity, arrhythmic risk profile, and pulmonary function is not influenced by intracoronary injection of bone marrow stem cells in patients with acute myocardial infarction

artículo científico publicado en 2011

Exudative pericarditis in a pregnant woman as the first sign of non-Hodgkin's lymphoma.

artículo científico publicado en 2011

Fibrinogen and d-dimer in contrasting relation with measures of wave reflection and arterial stiffness.

artículo científico publicado en 2012

Frequency of BCR-ABL gene mutations in Polish patients with chronic myeloid leukemia treated with imatinib: a final report of the MAPTEST study

artículo científico publicado en 2009

Gene expression profiling of acute myeloid leukemia samples from adult patients with AML-M1 and -M2 through boutique microarrays, real-time PCR and droplet digital PCR.

artículo científico publicado en 2017

Genetic investigation of biological materials from patients after stem cell transplantation based on autosomal as well as Y-chromosomal markers

artículo científico publicado en 2012

Glutaminase inhibitor CB-839 synergizes with carfilzomib in resistant multiple myeloma cells

artículo científico publicado en 2017

HLA-inferred extended haplotype disparity level is more relevant than the level of HLA mismatch alone for the patients survival and GvHD in T cell-replate hematopoietic stem cell transplantation from unrelated donor

artículo científico publicado en 2018

High response rate to bortezomib with or without dexamethasone in patients with relapsed or refractory multiple myeloma: results of a global phase 3b expanded access program

artículo científico publicado en 2008

Hodgkin lymphoma transformation of chronic lymphocytic leukemia: cases report and discussion

artículo científico publicado en 2013

Incidence and risk factors for central venous catheter-related thrombosis in hematological patients

artículo científico publicado en 2013

Influence of bone marrow stem cells on left ventricle perfusion and ejection fraction in patients with acute myocardial infarction of anterior wall: randomized clinical trial: Impact of bone marrow stem cell intracoronary infusion on improvement of

scientific article published on 17 December 2009

Inhibitory effects of bortezomib on platelet aggregation in patients with multiple myeloma

scientific article published on 02 June 2014

Liposomal cytarabine in the prophylaxis and treatment of CNS lymphoma: toxicity analysis in a retrospective case series study conducted at Polish Lymphoma Research Group Centers

artículo científico publicado en 2015

Mean platelet volume as a predictive marker for venous thromboembolism and mortality in patients treated for diffuse large B-cell lymphoma.

artículo científico publicado en 2016

Mean platelet volume as a predictive marker for venous thromboembolism in patients treated for Hodgkin lymphoma.

artículo científico publicado en 2018

Megakaryocytic blast crisis in a chronic myeloid leukemia patient with a rare variant of Philadelphia rearrangement t(9;22;22) and a constitutional translocation t(3;7)

artículo científico publicado en 2010

Mild chronic graft-versus-host disease may alleviate poor prognosis associated with FLT3 internal tandem duplication for adult acute myeloid leukemia following allogeneic stem cell transplantation with myeloablative conditioning in first complete re

artículo científico publicado en 2015

NPM1 alternative transcripts are upregulated in acute myeloid and lymphoblastic leukemia and their expression level affects patient outcome

Outcome of HLA-matched related allogeneic hematopoietic stem cell transplantation for patients with acute leukemia in first complete remission treated in Eastern European centers. Better results in recent years

artículo científico publicado en 2009

Outcomes of reduced-intensity transplantation for chronic myeloid leukemia: an analysis of prognostic factors from the Chronic Leukemia Working Party of the EBMT.

artículo científico publicado en 2005

Palifermin does not influence the incidence and severity of GvHD nor long-term survival of patients with hematological diseases undergoing HSCT.

artículo científico publicado en 2011

Prediction of venous thromboembolism in newly diagnosed patients treated for lymphoid malignancies: validation of the Khorana Risk Score

artículo científico publicado en 2017

Pretransplantation use of the second-generation tyrosine kinase inhibitors has no negative impact on the HCT outcome

artículo científico publicado en 2015

Prognostic factors and long-term outcome of autologous haematopoietic stem cell transplantation following a uniform-modified BEAM-conditioning regimen for patients with refractory or relapsed Hodgkin lymphoma: a single-center experience

artículo científico publicado en 2013

Quality of life in chronic myeloid leukaemia patients after haematopoietic cell transplantation pretreated with second-generation tyrosine kinase inhibitors

artículo científico publicado en 2016

Rituximab (Mabthera, Rituxan) in patients with recurrent indolent lymphoma: evaluation of safety and efficacy in a multicenter study.

artículo científico publicado en 2001

Role of Donor Activating KIR-HLA Ligand-Mediated NK Cell Education Status in Control of Malignancy in Hematopoietic Cell Transplant Recipients

artículo científico publicado en 2015

Second malignancies after autologous haematopoietic stem cell transplantation following modified BEAM conditioning regimen in patients with Hodgkin lymphoma - characteristics and risk factor analysis

artículo científico publicado en 2013

Simultaneous detection of mutations and copy number variation of NPM1 in the acute myeloid leukemia using multiplex ligation-dependent probe amplification

artículo científico publicado en 2016

Spontaneous hematological remission of acute myeloid leukemia

artículo científico publicado en 2014

Strategy of pre-emptive management of Epstein-Barr virus post-transplant lymphoproliferative disorder after stem cell transplantation: results of European transplant centers survey

artículo científico publicado en 2012

Successful treatment of pulmonary candidiasis and aspergillosis in patient with refractory Hodgkin lymphoma using micafungin - case study and brief literature review

artículo científico publicado en 2017

Superior outcomes associated with complete response in newly diagnosed multiple myeloma patients treated with nonintensive therapy: analysis of the phase 3 VISTA study of bortezomib plus melphalan-prednisone versus melphalan-prednisone

artículo científico publicado en 2010

Syngeneic transplantation in aplastic anemia: pre-transplant conditioning and peripheral blood are associated with improved engraftment: an observational study on behalf of the Severe Aplastic Anemia and Pediatric Diseases Working Parties of the Eur

artículo científico publicado en 2013

The Expression of the SLIT-ROBO Family in Adult Patients with Acute Myeloid Leukemia

scientific article published on 28 February 2019

The JAK2 V617F mutational status and allele burden may be related with the risk of venous thromboembolic events in patients with Philadelphia-negative myeloproliferative neoplasms.

artículo científico publicado en 2014

The JAK2 V617F mutational status and allele burden--authors' reply.

artículo científico publicado en 2015

The prognostic significance of surface dipeptidylpeptidase IV (CD26) expression in B-cell chronic lymphocytic leukemia.

artículo científico publicado en 2016

The relationship between mean platelet volume and thrombosis recurrence in patients diagnosed with antiphospholipid syndrome

artículo científico publicado en 2014

The roles of consolidation and maintenance therapy with novel agents after autologous stem cell transplantation in patients with multiple myeloma.

artículo científico publicado en 2014

Thrombotic complications of central venous catheters in hematooncological patients

artículo científico publicado el 1 de enero de 2010

Transient presence of clonal chromosomal aberrations in Ph-negative cells in patients with chronic myeloid leukemia remaining in deep molecular response on tyrosine kinase inhibitor treatment

artículo científico publicado en 2014

Treatment strategy based on gemcitabine-containing salvage chemotherapy used with intent to proceed to second stem cell transplant for patients with Hodgkin lymphoma relapsing after a prior autologous transplant

artículo científico publicado en 2012

Wyniki leczenia chorych na zespoły mielodysplastyczne z zastosowaniem transplantacji allogenicznych komórek krwiotwórczych: badanie wieloośrodkowe Polskiej Grupy ds. Leczenia Białaczek PALG

artículo científico publicado en 2015

Zalecenia Polskiej Grupy Szpiczakowej dotyczące rozpoznawania i leczenia szpiczaka plazmocytowego oraz innych dyskrazji plazmocytowych na rok 2015

artículo científico publicado en 2015

Zalecenia Polskiej Grupy Szpiczakowej dotyczące rozpoznawania i leczenia szpiczaka plazmocytowego oraz innych dyskrazji plazmocytowych na rok 2016

artículo científico publicado en 2016

Zalecenia Polskiej Grupy Szpiczakowej dotyczące rozpoznawania i leczenia szpiczaka plazmocytowego oraz innych dyskrazji plazmocytowych na rok 2017

artículo científico publicado en 2017

[Autologous stem cell transplantation in the treatment of primary systemic amyloidosis]

artículo científico publicado en 2009

[Point mutations of genes encoding proteins involvedin RNA splicing in patients with myelodysplastic syndromes]

artículo científico publicado en 2015

[Suppressive effect of high-dose chemotherapy (HDC) on the clonal growth of grafted peripheral blood granulocyte progenitors is reduced 72 hours after completion of HDC]

scientific article published on 01 May 2005

[The role of bone marrow cells immunophenotypic study by flow cytometry in diagnosing myelodysplastic syndrome]

artículo científico publicado en 2008

[Thrombotic complications following the treatment of multiple myeloma with new agents]

scientific article published on 01 December 2011

Lista de obras de Mieczysław Komarnicki

Activity of bortezomib in adult de novo and relapsed acute myeloid leukemia

Addition of cladribine to daunorubicin and cytarabine increases complete remission rate after a single course of induction treatment in acute myeloid leukemia. Multicenter, phase III study

Analysis of boutique arrays: a universal method for the selection of the optimal data normalization procedure

Assessing the efficacy of allogeneic hematopoietic stem cells transplantation (allo-HSCT) by analyzing survival end points in defined groups of acute myeloid leukemia patients: a retrospective, multicenter Polish Adult Leukemia Group study

Assessment of coagulation profile by thromboelastometry in adult patients with cyanotic congenital heart disease

Autologous hematopoietic stem cell transplant for progressive diffuse systemic sclerosis: procedural success and clinical outcome in 5-year follow-up

Autologous stem cell transplantation as consolidation therapy for patients with peripheral T cell lymphoma in first remission: long-term outcome and risk factors analysis

B-Cell Chronic Lymphocytic Leukemia with 11q22.3 Rearrangement in Patient with Chronic Myeloid Leukemia Treated with Imatinib

Bendamustine-based therapy as first-line treatment for non-Hodgkin lymphoma

Bleeding complications after arthroscopy in a JAK2V617F-positive patient with essential thrombocythemia and acquired von Willebrand syndrome (AVWS).

Bortezomib has little ex vivo activity in chronic myeloid leukemia: individual tumor response testing comparative study in acute and chronic myeloid leukemia.

Bortezomib in combination with thalidomide and dexamethasone--a successful treatment regimen in refractory extramedullary multiple myeloma

Cancer procoagulant in patients with adenocarcinomas.

Characterization and significance of the Philadelphia negative/BCR-ABL1 positive rearrangement or masked Philadelphia translocation in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a single-center study

Cladribine, but not fludarabine, added to daunorubicin and cytarabine during induction prolongs survival of patients with acute myeloid leukemia: a multicenter, randomized phase III study.

Clinical usefulness of serum free light chains measurement in patients with multiple myeloma: comparative analysis of two different tests

Coagulation profile in patients with H1N1 influenza A infection undergoing treatment for haematological malignancies

Comparative proteome analysis of acute myeloid leukemia with and without maturation.

Comparative proteomic profiling of sera from patients with refractory multiple myeloma reveals potential biomarkers predicting response to bortezomib-based therapy.

Comparative proteomics in acute myeloid leukemia

Comparison of clofarabine activity in childhood and adult acute leukemia: individual tumor response study.

Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma

Dasatinib treatment can overcome imatinib and nilotinib resistance in CML patient carrying F359I mutation of BCR-ABL oncogene

Dasatinib-induced complete molecular response after allogeneic hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia resistant to prior imatinib-containing regimen: a case report and discussion

Donor NK cell licensing in control of malignancy in hematopoietic stem cell transplant recipients.

Esterase D and gamma 1 actin level might predict results of induction therapy in patients with acute myeloid leukemia without and with maturation

Evaluation of risk factors and assessment models for predicting venous thromboembolism in lung cancer patients.

Evaluation of the ThroLy score for the prediction of venous thromboembolism in newly diagnosed patients treated for lymphoid malignancies in clinical practice

Evaluation of thromboelastometry parameters as predictive markers for sinusoidal obstruction syndrome in patients undergoing allogeneic stem cell transplantation for acute leukaemia.

Exercise capacity, arrhythmic risk profile, and pulmonary function is not influenced by intracoronary injection of bone marrow stem cells in patients with acute myocardial infarction

Exudative pericarditis in a pregnant woman as the first sign of non-Hodgkin's lymphoma.

Fibrinogen and d-dimer in contrasting relation with measures of wave reflection and arterial stiffness.

Frequency of BCR-ABL gene mutations in Polish patients with chronic myeloid leukemia treated with imatinib: a final report of the MAPTEST study

Gene expression profiling of acute myeloid leukemia samples from adult patients with AML-M1 and -M2 through boutique microarrays, real-time PCR and droplet digital PCR.

Genetic investigation of biological materials from patients after stem cell transplantation based on autosomal as well as Y-chromosomal markers

Glutaminase inhibitor CB-839 synergizes with carfilzomib in resistant multiple myeloma cells

HLA-inferred extended haplotype disparity level is more relevant than the level of HLA mismatch alone for the patients survival and GvHD in T cell-replate hematopoietic stem cell transplantation from unrelated donor

High response rate to bortezomib with or without dexamethasone in patients with relapsed or refractory multiple myeloma: results of a global phase 3b expanded access program

Hodgkin lymphoma transformation of chronic lymphocytic leukemia: cases report and discussion

Incidence and risk factors for central venous catheter-related thrombosis in hematological patients

Influence of bone marrow stem cells on left ventricle perfusion and ejection fraction in patients with acute myocardial infarction of anterior wall: randomized clinical trial: Impact of bone marrow stem cell intracoronary infusion on improvement of

Inhibitory effects of bortezomib on platelet aggregation in patients with multiple myeloma

Liposomal cytarabine in the prophylaxis and treatment of CNS lymphoma: toxicity analysis in a retrospective case series study conducted at Polish Lymphoma Research Group Centers

Mean platelet volume as a predictive marker for venous thromboembolism and mortality in patients treated for diffuse large B-cell lymphoma.

Mean platelet volume as a predictive marker for venous thromboembolism in patients treated for Hodgkin lymphoma.

Megakaryocytic blast crisis in a chronic myeloid leukemia patient with a rare variant of Philadelphia rearrangement t(9;22;22) and a constitutional translocation t(3;7)

Mild chronic graft-versus-host disease may alleviate poor prognosis associated with FLT3 internal tandem duplication for adult acute myeloid leukemia following allogeneic stem cell transplantation with myeloablative conditioning in first complete re

NPM1 alternative transcripts are upregulated in acute myeloid and lymphoblastic leukemia and their expression level affects patient outcome

Outcome of HLA-matched related allogeneic hematopoietic stem cell transplantation for patients with acute leukemia in first complete remission treated in Eastern European centers. Better results in recent years

Outcomes of reduced-intensity transplantation for chronic myeloid leukemia: an analysis of prognostic factors from the Chronic Leukemia Working Party of the EBMT.

Palifermin does not influence the incidence and severity of GvHD nor long-term survival of patients with hematological diseases undergoing HSCT.

Prediction of venous thromboembolism in newly diagnosed patients treated for lymphoid malignancies: validation of the Khorana Risk Score

Pretransplantation use of the second-generation tyrosine kinase inhibitors has no negative impact on the HCT outcome

Prognostic factors and long-term outcome of autologous haematopoietic stem cell transplantation following a uniform-modified BEAM-conditioning regimen for patients with refractory or relapsed Hodgkin lymphoma: a single-center experience

Quality of life in chronic myeloid leukaemia patients after haematopoietic cell transplantation pretreated with second-generation tyrosine kinase inhibitors

Rituximab (Mabthera, Rituxan) in patients with recurrent indolent lymphoma: evaluation of safety and efficacy in a multicenter study.

Role of Donor Activating KIR-HLA Ligand-Mediated NK Cell Education Status in Control of Malignancy in Hematopoietic Cell Transplant Recipients

Second malignancies after autologous haematopoietic stem cell transplantation following modified BEAM conditioning regimen in patients with Hodgkin lymphoma - characteristics and risk factor analysis

Simultaneous detection of mutations and copy number variation of NPM1 in the acute myeloid leukemia using multiplex ligation-dependent probe amplification

Spontaneous hematological remission of acute myeloid leukemia

Strategy of pre-emptive management of Epstein-Barr virus post-transplant lymphoproliferative disorder after stem cell transplantation: results of European transplant centers survey

Successful treatment of pulmonary candidiasis and aspergillosis in patient with refractory Hodgkin lymphoma using micafungin - case study and brief literature review

Superior outcomes associated with complete response in newly diagnosed multiple myeloma patients treated with nonintensive therapy: analysis of the phase 3 VISTA study of bortezomib plus melphalan-prednisone versus melphalan-prednisone

Syngeneic transplantation in aplastic anemia: pre-transplant conditioning and peripheral blood are associated with improved engraftment: an observational study on behalf of the Severe Aplastic Anemia and Pediatric Diseases Working Parties of the Eur

The Expression of the SLIT-ROBO Family in Adult Patients with Acute Myeloid Leukemia

The JAK2 V617F mutational status and allele burden may be related with the risk of venous thromboembolic events in patients with Philadelphia-negative myeloproliferative neoplasms.

The JAK2 V617F mutational status and allele burden--authors' reply.

The prognostic significance of surface dipeptidylpeptidase IV (CD26) expression in B-cell chronic lymphocytic leukemia.

The relationship between mean platelet volume and thrombosis recurrence in patients diagnosed with antiphospholipid syndrome

The roles of consolidation and maintenance therapy with novel agents after autologous stem cell transplantation in patients with multiple myeloma.

Thrombotic complications of central venous catheters in hematooncological patients

Transient presence of clonal chromosomal aberrations in Ph-negative cells in patients with chronic myeloid leukemia remaining in deep molecular response on tyrosine kinase inhibitor treatment

Treatment strategy based on gemcitabine-containing salvage chemotherapy used with intent to proceed to second stem cell transplant for patients with Hodgkin lymphoma relapsing after a prior autologous transplant

Wyniki leczenia chorych na zespoły mielodysplastyczne z zastosowaniem transplantacji allogenicznych komórek krwiotwórczych: badanie wieloośrodkowe Polskiej Grupy ds. Leczenia Białaczek PALG

Zalecenia Polskiej Grupy Szpiczakowej dotyczące rozpoznawania i leczenia szpiczaka plazmocytowego oraz innych dyskrazji plazmocytowych na rok 2015

Zalecenia Polskiej Grupy Szpiczakowej dotyczące rozpoznawania i leczenia szpiczaka plazmocytowego oraz innych dyskrazji plazmocytowych na rok 2016

Zalecenia Polskiej Grupy Szpiczakowej dotyczące rozpoznawania i leczenia szpiczaka plazmocytowego oraz innych dyskrazji plazmocytowych na rok 2017

[Autologous stem cell transplantation in the treatment of primary systemic amyloidosis]

[Point mutations of genes encoding proteins involvedin RNA splicing in patients with myelodysplastic syndromes]